By Sneha S K and Maggie Fick (Reuters) -Bristol Myers Squibb said on Monday it plans to launch its schizophrenia drug, ...
With a Sept. 29 deadline looming for pharmaceutical companies to adhere to President Donald Trump’s most favored nation drug ...
Karuna Therapeutics and Bristol Myers Squibb are winners of the 2025 Gizmodo Science Fair for their research and development ...
The company, which is developing a competitor to Cobenfy, aims to become one of rare biotechs to price a large IPO of late.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback